EVALUATION OF APC RESISTANCE IN THE PLASMA OF PATIENTS WITH Q506 MUTATION OF FACTOR-V (FACTOR-V LEIDEN) AND TREATED BY ORAL ANTICOAGULANTS

被引：0
|
作者：
CADROY, Y
SIE, P
ALHENCGELAS, M
AIACH, M
机构：
[1] HOP PURPAN,HEMATOL LAB,F-31059 TOULOUSE,FRANCE
[2] HOP BROUSSAIS,HEMOSTASE LAB,F-75674 PARIS,FRANCE
来源：
THROMBOSIS AND HAEMOSTASIS | 1995年 / 73卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：734 / 735
页数：2
相关论文
共 50 条
  • [41] RESISTANCE TO ACTIVATED PROTEIN-C (APC) - INFLUENCE OF FACTOR-V LEVELS
    COLUCCI, M
    CIAVARELLA, N
    GILIBERTI, MG
    SEMERARO, N
    THROMBOSIS AND HAEMOSTASIS, 1994, 72 (06) : 987 - 988
  • [42] FACTOR-V LEIDEN AND RISKS OF RECURRENT IDIOPATHIC VENOUS THROMBOEMBOLISM
    RIDKER, PM
    MILETICH, JP
    STAMPFER, MJ
    GOLDHABER, SZ
    LINDPAINTNER, K
    HENNEKENS, CH
    CIRCULATION, 1995, 92 (10) : 2800 - 2802
  • [43] Activated protein C resistance and Q506 mutation of factor V in venous thromboembolism.
    Garcin, JM
    Plotton, N
    Collet, JP
    AlhencGelas, M
    Emmerich, J
    Chanudet, X
    Larroque, P
    SEMAINE DES HOPITAUX, 1997, 73 (25-26): : 793 - 799
  • [44] Venous thrombosis in elderly: Prevalence of factor V gene mutation Q506
    Andre, E
    AlhenceGelas, M
    Siguret, V
    Gaussem, P
    THROMBOSIS AND HAEMOSTASIS, 1997, : P1262 - P1262
  • [45] FACTOR-V LEIDEN GENE MUTATION AND THROMBIN GENERATION IN RELATION TO THE DEVELOPMENT OF ACUTE STROKE
    CATTO, A
    CARTER, A
    IRELAND, H
    BAYSTON, TA
    PHILIPPOU, H
    BARRETT, J
    LANE, DA
    GRANT, PJ
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1995, 15 (06) : 783 - 785
  • [46] FRACTIONATION OF FACTOR-V FROM HUMAN PLASMA
    GIDDINGS, JC
    THROMBOSIS ET DIATHESIS HAEMORRHAGICA, 1974, 31 (03): : 457 - 468
  • [47] Increased plasma prothrombin levels are associated with the factor V:Q506 mutation in patients with venous thromboembolism.
    Prondzinski, MV
    Ehrenforth, S
    Czwalinna, A
    Wermes, C
    Rutjes, J
    Eisert, R
    Scharrer, I
    Ganser, A
    BLOOD, 1999, 94 (10) : 244A - 244A
  • [48] Patients with persistent APC-resistance without factor V Leiden mutation
    Schwarz, T
    Siegert, G
    Mikulin, U
    Gehrisch, S
    Runge, E
    Berg, LP
    Koch, R
    Schellong, SM
    VASA-JOURNAL OF VASCULAR DISEASES, 2001, 30 (01): : 24 - 27
  • [49] DVT FOLLOWING ORAL-CONTRACEPTIVE THERAPY IN ASSOCIATION WITH HOMOZYGOUS FACTOR-V LEIDEN
    ASLAM, S
    STANDEN, GR
    MORSE, C
    SCOTT, GL
    CLINICAL AND LABORATORY HAEMATOLOGY, 1995, 17 (01): : 99 - 100
  • [50] INCREASED RISK OF VENOUS THROMBOSIS IN ORAL-CONTRACEPTIVE USERS WHO ARE CARRIERS OF FACTOR-V LEIDEN MUTATION
    VANDENBROUCKE, JP
    KOSTER, T
    BRIET, E
    REITSMA, PH
    BERTINA, RM
    ROSENDAAL, FR
    LANCET, 1994, 344 (8935): : 1453 - 1457
12345